Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hyperglycemia × Alpelisib × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Ovarian Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hyperglycemia 1 Advanced or Metastatic ER+ Breast Cancer 1 Advanced Breast Cancer 1

Interventions

volagidemab 2 dapagliflozin 1 Metformin 1 Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04899349 2024-10-09

EPIK-B4

Novartis

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡